Nobel Biotech Co. – Trademark Portfolio

Entity Type: 03

Nobel Biotech Co. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RWND. The owner is based in Orlando, FL.

7726 Winegard Rd., Suite A-2744

Orlando, FL 34786

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PIINK
PIINK
Abandoned 2022
RWND
RWND
Registered 2022

Trademark Classifications

Nobel Biotech Co.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Nobel Biotech Co. have?

Nobel Biotech Co. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Nobel Biotech Co. file in?

Nobel Biotech Co. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Nobel Biotech Co.'s most well-known trademarks?

Nobel Biotech Co.'s registered trademark portfolio includes well-known marks such as RWND. These are among 1 currently registered trademark in the portfolio.

What is Nobel Biotech Co.'s trademark registration success rate?

Nobel Biotech Co. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.